Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma 2025-09-15 12:11
Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101 2025-09-15 08:00
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq 2025-09-12 20:00
Smartee and Shanghai Ninth People's Hospital Win First Prize at Shanghai Science and Technology Progress Awards 2025-09-12 10:03
Amazfit Announces Olympic Medalist Grant Fisher as New Brand Ambassador 2025-09-12 07:30
Zhimeng Biopharma's Investigational Drug Approved to Initiate Phase 2 Epilepsy Clinical Trial in China 2025-09-12 00:00
Datasea Secures Landmark Agreement for First Acoustic Wearable Technology Contract, Marking Entry into the $1 Trillion Market 2025-09-11 21:30
GLOBAL FIRST "High-Definition Image": Decoding the "Code of Youth" - LivingPhoenix's POGMENT Collagen Breakthrough Fills Global Gap 2025-09-11 21:27
Lunit Awarded Major National Tender in France, Expanding Access to Breast AI in Public Hospitals 2025-09-11 21:00
YolTech Therapeutics Raises $45 Million in Series B Financing Led by AstraZeneca-CICC 2025-09-11 20:05
Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy 2025-09-11 20:00
Health In Tech to Host Annual Meeting of Stockholders 2025-09-11 04:30
Shineco Achieves Mass Production of High-Purity Physical Phospholipids, Breaking Foreign Monopoly and Unlocking Innovation Across Industries 2025-09-10 21:30
C-Ray Therapeutics Supports Mednovo's Phase III Clinical Trial with First Patient Dosed for Lutetium [177Lu] Oxodotreotide Injection 2025-09-10 21:30
LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee 2025-09-10 20:10
ImmVira Announces First-in-Human Data of Engineered Exosome MVR-EX105 for Fat Reduction and Muscle Preservation by Topical Application at 2025 Annual Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders 2025-09-10 10:49
Cadonilimab(PD-1/CTLA-4) plus Pulocimab (VEGFR-2) Combination Therapy Shows Promising Results in IO-Resistant Non-Small Cell Lung Cancer in Oral Presentation at the 2025 WCLC 2025-09-10 10:40
TCI Biotech Strengthens Global Leadership Team with Appointment of Sales VP Tony Hatori and Strategic Consultant Alan Roberts 2025-09-09 23:00
iRegene Therapeutics Secures Series B+ Financing Following FDA Fast Track Designation for its Flagship Product NouvNeu001 2025-09-09 21:00
BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products 2025-09-09 20:30
1 16 17 18 19 20 871